A 52-year-old man from Delhi presents to the emergency department with a 3-day history of fever (39.5°C), productive cough with rusty sputum, and pleuritic chest pain. He has a history of chronic alcoholism and was found unconscious at home. On examination, he is tachypneic (RR 28/min), BP 100/65 mmHg, and has consolidation on the left lower lobe. A lumbar puncture is performed; CSF analysis shows: protein 180 mg/dL, glucose 25 mg/dL (serum glucose 120 mg/dL), and 450 WBC/µL (90% neutrophils). Gram stain of CSF reveals gram-positive diplococci. Which of the following is the most appropriate empirical antibiotic regimen for this patient?

Explanation

## Clinical Presentation & Diagnosis This patient presents with **bacterial meningitis** with pneumonia, evidenced by: - Meningeal signs (fever, altered consciousness) - CSF pleocytosis with neutrophil predominance - Low CSF glucose with high protein (classic for bacterial meningitis) - Gram-positive diplococci on Gram stain → **Streptococcus pneumoniae** - Risk factors: chronic alcoholism, aspiration risk ## Empirical Therapy for Pneumococcal Meningitis **Key Point:** Empirical meningitis regimens must cover *S. pneumoniae* with high CNS penetration AND account for potential penicillin/cephalosporin resistance. **High-Yield:** The gold standard empirical regimen for community-acquired bacterial meningitis in adults is: | Component | Rationale | |-----------|----------| | **Ceftriaxone 2 g IV 12-hourly** | Third-generation cephalosporin; excellent meningeal penetration; covers susceptible and intermediate-resistance pneumococci | | **Vancomycin 15–20 mg/kg IV 8–12-hourly** | Added for coverage of penicillin-resistant *S. pneumoniae* (PRSP); achieves therapeutic CSF levels when meninges inflamed | | **Rifampicin 600 mg IV 12-hourly** | Adjunctive agent; excellent CSF penetration; synergistic with vancomycin against PRSP | **Clinical Pearl:** Vancomycin monotherapy is inadequate for meningitis because CSF penetration is poor (~20% of serum levels) even with inflamed meninges. The triple regimen ensures coverage of all resistance patterns while awaiting culture and susceptibility results. **Warning:** Do NOT use penicillin G monotherapy in meningitis — resistance rates in *S. pneumoniae* are high globally, including India, and penicillin CSF penetration is suboptimal. ## Why This Patient Needs Triple Therapy 1. **Unknown resistance pattern** — culture results pending 2. **High-risk patient** — alcoholism associated with PRSP 3. **CNS infection** — requires maximum bactericidal activity and CSF penetration 4. **Meningitis mortality** — empirical broad coverage is life-saving [cite:Harrison 21e Ch 297]